36
Views
13
CrossRef citations to date
0
Altmetric
VII. BIOLOGICAL STUDIES OF OLIGOMERS

Pharmacokinetic Properties of Phosphorothioate Oligonucleotides

, , , , , , , & show all
Pages 1689-1693 | Published online: 16 Aug 2006

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Richard S Geary. (2009) Antisense oligonucleotide pharmacokinetics and metabolism. Expert Opinion on Drug Metabolism & Toxicology 5:4, pages 381-391.
Read now
Scott P. Henry, Arthur A. Levin, Kimber White & John H. Mennear. (2006) Assessment of the Effects of ISIS 2302, an Anti-Sense Inhibitor of Human ICAM-1, on Cellular and Humoral Immunity in Mice. Journal of Immunotoxicology 3:4, pages 199-211.
Read now
William R Shanahan Jr. (1999) ISIS 2302, an antisense inhibitor of intercellular adhesion molecule 1. Expert Opinion on Investigational Drugs 8:9, pages 1417-1429.
Read now
Dieter Hüsken, Andrea Deichert, Jonathan Hall & Robert Häner. (1999) Combinatorial Library of Artificial Ribonucleases. Nucleosides and Nucleotides 18:6-7, pages 1507-1511.
Read now

Articles from other publishers (9)

Cristina R. Hofman & David R. Corey. (2023) Targeting RNA with synthetic oligonucleotides: Clinical success invites new challenges. Cell Chemical Biology.
Crossref
Michaela Kearney, Paul R. Cooper, Anthony J. Smith & Henry F. Duncan. (2018) Epigenetic Approaches to the Treatment of Dental Pulp Inflammation and Repair: Opportunities and Obstacles. Frontiers in Genetics 9.
Crossref
Gitanjali Kher, Sonia Trehan & Ambikanandan Misra. 2011. Challenges in Delivery of Therapeutic Genomics and Proteomics. Challenges in Delivery of Therapeutic Genomics and Proteomics 325 386 .
Rosie Z. Yu, Tae-Won Kim, An Hong, Tanya A. Watanabe, Hans J. Gaus & Richard S. Geary. (2007) Cross-Species Pharmacokinetic Comparison from Mouse to Man of a Second-Generation Antisense Oligonucleotide, ISIS 301012, Targeting Human Apolipoprotein B-100. Drug Metabolism and Disposition 35:3, pages 460-468.
Crossref
Tanya A. WatanabeRichard S. GearyArthur A. Levin. (2006) Plasma Protein Binding of an Antisense Oligonucleotide Targeting Human ICAM-1 (ISIS 2302). Oligonucleotides 16:2, pages 169-180.
Crossref
Lilit MasarjianAnn De PeysterArthur A. LevinDavid K. Monteith. (2004) Distribution and Excretion of a Phosphorothioate Oligonucleotide in Rats with Experimentally Induced Renal Injury. Oligonucleotides 14:4, pages 299-310.
Crossref
Rosie Z. Yu, Richard S. Geary, David K. Monteith, John Matson, Loanne Truong, Jon Fitchett & Arthur A. Levin. (2004) Tissue Disposition of 2′‐O‐(2‐methoxy) ethyl Modified Antisense Oligonucleotides in Monkeys. Journal of Pharmaceutical Sciences 93:1, pages 48-59.
Crossref
JANET M. LEEDS, SCOTT P. HENRY, RICHARD GEARY, TODD BURCKIN & ARTHUR A. LEVIN. (2000) Comparison of the Pharmacokinetics of Subcutaneous and Intravenous Administration of a Phosphorothioate Oligodeoxynucleotide in Cynomolgus Monkeys. Antisense and Nucleic Acid Drug Development 10:6, pages 435-441.
Crossref
Arthur A Levin. (1999) A review of issues in the pharmacokinetics and toxicology of phosphorothioate antisense oligonucleotides. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression 1489:1, pages 69-84.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.